Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease (original) (raw)
References
Donowitz M: Arachadonic acid metabolites and their role in inflammatory bowel disease. Gastroenterology 88:580, 1985 Google Scholar
Sharon P, Stenson WF: Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86:453, 1984 Google Scholar
Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu, Watanabe M, Aiso S, Tsuchiya M: Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease. Dig Dis Sci 33:951–955, 1988 Google Scholar
Broberger O, Perlmann P: Autoantibodies in human ulcerative colitis. J Exp Med 110:657, 1959 Google Scholar
Whorwell PJ, Bennett P, Tanner AR, Wright R: Monocyte function in Crohn's disease and ulcerative colitis. Digestion 22:271–275, 1981 Google Scholar
Kurt-Jones EA, Kiely JM, Unanue ER: Conditions required for expression of membrane IL-1 on B-cells. J Immunol 135:1548–1550, 1985 Google Scholar
Dinarello CA: Interleukin-1 and its biologically related cytokines. Adv Immunol 44:153–205, 1989 Google Scholar
Krane S, Dayer JM, Simon CS, Byrne S: Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulating collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin. Collagen Rel Res 5:99–117, 1985 Google Scholar
Mahida YR, Wu KC, Jewell DP: Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 30:835–838, 1989 Google Scholar
Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 31:686–689, 1990 Google Scholar
Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV: Human tumor necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312:724–729 1984 Google Scholar
Scheurich P, Thoma B, Ucer U, Pfizenmaier K: Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)α: Induction of TNF receptors on human T cells and TNFα mediated enhancement of T-cell responses. J Immunol 138:1786–1790, 1987 Google Scholar
Jelnick DF, Lipsky PE: Enhancement of human B-cell proliferation and differentiation by tumor necrosis factor α and interleukin 1. J Immunol 139:2970–2976, 1987 Google Scholar
Beutler B, Milsark IW, Cerami A: Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science (Washington, DC) 229:869–871, 1985 Google Scholar
Hofman FM, Hinton DR, Johnson K, Merrill JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607–612 1989 Google Scholar
Van Snick J: Interleukin 6: An overview. Annu Rev Immunol 8:253–278, 1990 Google Scholar
Raynal MC, Liu Z, Hirano T, Mayer L, Kishimoto T, Chen-Kiang S: Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation. Proc Natl Acad Sci USA 86:8024–8028, 1989 Google Scholar
Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H: Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251–7255, 1987 Google Scholar
Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T: Il-6/BSF-2 functions as a killer helper factor in the_in vitro_ induction of cytotoxic T cells. J Immunol 141:1543–1549, 1988 Google Scholar
Luger TA, Krutmann J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Kock A, Micksche M, Malejczyk J, Schauer E, May LT, Sehgal PB: IFN/IL-6 augments the activity of human natural killer cells. J Immunol 143:1206–1209, 1989 Google Scholar
Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y, Yoshizaki K, Hirano T, Kishimoto T: Involvement of IL-6 in mesangial proliferative glomerulonephtitis. J Immunol 143:3949–3955, 1989 Google Scholar
Bataille R, Jourdan M, Zhang XG, Klein B: Serum levels of Interleukin 6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasia. J Clin Invest 84:2008–2011, 1989 Google Scholar
Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivelis M, Steinman RM, Sehgal PB, May LT: IL-6/IFN-B2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. J Immunol 143:2153–2159, 1989 Google Scholar
Jourdan M, Bataille R, Seguin J, Zhang XG, Chaptal PA, Klein B: Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum 33:398–402, 1990 Google Scholar
De Dombal FT, Burton IL, Clamp SE, Goligher JC: Short term course and prognosis of Crohn's disease. Gut 15:435–443, 1974 Google Scholar
Glisin V, Crkvenjakov R, Byus D: Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13:2633–2637, 1973 Google Scholar
Innis MA, Gelfand DH, Sninsky JJ: PCR Protocols. New York, Academic Press, 1989 Google Scholar
Isaacs K, Sartor RB, Wang A, Haskill JS: Profiles of cytokine activation in inflammatory bowel disease tissue: Measurement by cDNA amplification. Gastroenterology 98:455A 1990 Google Scholar
Radema SA, van Deventer SJ, Cerami A: Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis. Gastroenterology 100:1180–1186, 1991 Google Scholar
Sehgal PB, Helfgott DC, Santhanam U, Tatter SB, Clarick RH, Ghrayeb J, May LT: Regulation of the acute phase and immune response in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblasts. J Exp Med 167:1951–1956, 1988 Google Scholar
Walz G, Zanker B, Barth C, Wieder KJ, Clark SC, Strom TB: Transcriptional modulation of human IL-6 gene expression by verapamil. J Immunol 144:4242–4248, 1990 Google Scholar
Meijer CJ, Bosman FT, Lindeman J: Evidence for predominant involvement of the B-cell systems in the inflammatory process in Crohn's disease. Scand J Gastroenterol 14:21–32, 1979 Google Scholar
Wu KC, Mahida YR, Priddle JD, Jewell DP: Effect of human intestinal macrophages on immunoglobulin production by human intestinal mononuclear cells isolated from patients with inflammatory bowel disease. Clin Exp Immunol 79:35–40, 1990 Google Scholar
Fiocchi C, Battisto JR, Farmer RG: Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T-cells and enhanced proliferation to_Staphlococcus aureus_ and lipopolysaccharides. Dig Dis Sci 26:728–736, 1981 Google Scholar
Knudsen PJ, Dinarello CA, Strom TB: Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 139:4129–4134, 1987 Google Scholar
Zanker B, Walz G, Wieder KJ, Strom TB: Evidence that glucocorticoids block expression of the human interleukin-6 gene by accessory cells. Transplantation 49:183–185, 1990 Google Scholar
Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A: Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232:977–980, 1986 Google Scholar
Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, Eugui EM, Allison AC: Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 85:1204–1208, 1988 Google Scholar
Almawi WY, Lipman ML, Stevens AC, Zanker B, Hadro ET, Strom TB: Abrogation of glucocorticosteroid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-γ. J Immunol 146:3523–3527, 1991 Google Scholar